One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Shaping the Future of Veterans’ Health Care
Linda McCauley, Ph.D., R.N., and Kenneth S. Ramos, M.D., Ph.D.
doi : 10.1056/NEJMp2006123
N Engl J Med 2020; 383:1801-1804
#WhiteCoatsForBlackLives — Addressing Physicians’ Complicity in Criminalizing Communities
Jamila Perritt, M.D., M.P.H.
doi : 10.1056/NEJMp2023305
N Engl J Med 2020; 383:1804-1806
“A Menace to the Public Health” — Contact Tracing and the Limits of Persuasion
Graham Mooney, Ph.D.
doi : 10.1056/NEJMp2021887
N Engl J Med 2020; 383:1806-1808
On Grieving for the Out-of-Practice
David Weinstock, M.D.
doi : 10.1056/NEJMp2003297
N Engl J Med 2020; 383:1809-1811
Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impact
Connie Celum, M.D., M.P.H., Ruanne Barnabas, D.Phil., M.B., Ch.B., Myron S. Cohen, M.D., Ann Collier, M.D., Wafaa El-Sadr, M.D., M.P.H., King K. Holmes, M.D., Ph.D., Christine Johnston, M.D., M.P.H., and Peter Piot, M.D., Ph.D.
doi : 10.1056/NEJMp2022269
N Engl J Med 2020; 383:e106
Emergency Use Authorization of Covid Vaccines — Safety and Efficacy Follow-up Considerations
Philip R. Krause, M.D., and Marion F. Gruber, Ph.D.
doi : 10.1056/NEJMp2031373
N Engl J Med 2020; 383:e107
Community Health Workers and Covid-19 — Addressing Social Determinants of Health in Times of Crisis and Beyond
Patricia J. Peretz, M.P.H., Nadia Islam, Ph.D., and Luz Adriana Matiz, M.D.
doi : 10.1056/NEJMp2022641
N Engl J Med 2020; 383:e108
Remdesivir for the Treatment of Covid-19 — Final Report
John H. Beigel, M.D., Kay M. Tomashek, M.D., M.P.H., Lori E. Dodd, Ph.D., Aneesh K. Mehta, M.D., Barry S. Zingman, M.D., Andre C. Kalil, M.D., M.P.H., Elizabeth Hohmann, M.D., Helen Y. Chu, M.D., M.P.H., Annie Luetkemeyer, M.D., Susan Kline, M.D., M.P.H., Diego Lopez de Castilla, M.D., M.P.H., Robert W. Finberg, M.D.,
doi : 10.1056/NEJMoa2007764
N Engl J Med 2020; 383:1813-1826
Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman, M.D., M.P.H., David C.B. Lye, M.B., B.S., David S. Hui, M.D., Kristen M. Marks, M.D., Raffaele Bruno, M.D., Rocio Montejano, M.D., Christoph D. Spinner, M.D., Massimo Galli, M.D., Mi-Young Ahn, M.D., Ronald G. Nahass, M.D., Yao-Shen Chen, M.D., Devi SenGupta, M.D.,
doi : 10.1056/NEJMoa2015301
N Engl J Med 2020; 383:1827-1837
Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro and efficacy in animal models of coronavirus disease 2019 (Covid-19).
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf, M.D., Aernoud T.L. Fiolet, M.D., Arend Mosterd, M.D., John W. Eikelboom, M.D., Astrid Schut, M.Sc., Tjerk S.J. Opstal, M.D., Salem H.K. The, M.D., Xiao-Fang Xu, M.D., Mark A. Ireland, M.D., Timo Lenderink, M.D., Donald Latchem, M.D., Pieter Hoogslag, M.D.,
doi : 10.1056/NEJMoa2021372
N Engl J Med 2020; 383:1838-1847
Evidence from a recent trial has shown that the antiinflammatory effects of colchicine reduce the risk of cardiovascular events in patients with recent myocardial infarction, but evidence of such a risk reduction in patients with chronic coronary disease is limited.
Screening and Intervention to Prevent Falls and Fractures in Older People
Sarah E. Lamb, D.Phil., Julie Bruce, Ph.D., Anower Hossain, Ph.D., Chen Ji, Ph.D., Roberta Longo, Ph.D., Ranjit Lall, Ph.D., Chris Bojke, Ph.D., Claire Hulme, Ph.D., Emma Withers, H.N.D., Susanne Finnegan, Ph.D., Ray Sheridan, M.R.C.P., Keith Willett, M.D.,
doi : 10.1056/NEJMoa2001500
N Engl J Med 2020; 383:1848-1859
Community screening and therapeutic prevention strategies may reduce the incidence of falls in older people. The effects of these measures on the incidence of fractures, the use of health resources, and health-related quality of life are unknown.
Lineage-Independent Tumors in Bilateral Neuroblastoma
Tim H.H. Coorens, M.Phil., Sarah J. Farndon, M.B., B.S., Thomas J. Mitchell, B.M., B.Ch., D.Phil., Neha Jain, M.B., B.S., Sangjin Lee, M.Phil., Michael Hubank, Ph.D., Neil Sebire, M.B., B.S., Ph.D., John Anderson, M.B., B.S., Ph.D., and Sam Behjati, B.M., B.Ch., Ph.D.
doi : 10.1056/NEJMoa2000962
N Engl J Med 2020; 383:1860-1865
Migraine
Messoud Ashina, M.D., Ph.D., D.M.Sci.
doi : 10.1056/NEJMra1915327
N Engl J Med 2020; 383:1866-1876
Auricular Hematoma
Ashley L. Miller, M.D., and Michael S. Cohen, M.D.
doi : 10.1056/NEJMicm2004765
N Engl J Med 2020; 383:1877
Necrotizing Scleritis
Natalia Lorenzana Blanco, M.D., and Nicolas Alejandre Alba, M.D., Ph.D.
doi : 10.1056/NEJMicm2004836
N Engl J Med 2020; 383:e110
In the Absence of Proof
Sameer Kushwaha, M.D., Isaac I. Bogoch, M.D., Susanna Mak, M.D., Ph.D., Patrik Rogalla, M.D., Ph.D., and Allan S. Detsky, M.D., Ph.D.
doi : 10.1056/NEJMcps2002083
N Engl J Med 2020; 383:1878-1884
Remdesivir — An Important First Step
Raphael Dolin, M.D., and Martin S. Hirsch, M.D.
doi : 10.1056/NEJMe2018715
N Engl J Med 2020; 383:1886-1887
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today
Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., and Stephen Morrissey, Ph.D.
doi : 10.1056/NEJMe2032843
N Engl J Med 2020; 383:e123
Sourcing Photoreceptor-like Cells for Treating Vision Loss
Rajendra S. Apte, M.D., Ph.D.
doi : 10.1056/NEJMcibr2027602
N Engl J Med 2020; 383:1888-1890
Compression Therapy to Prevent Recurrent Cellulitis of the Leg
doi : 10.1056/NEJMc2029458
N Engl J Med 2020; 383:1891-1892
The “All of Us” Program and Indigenous Peoples
doi : 10.1056/NEJMc2028907
N Engl J Med 2020; 383:1892-1893
Lupus Anticoagulant in Patients with Covid-19
doi : 10.1056/NEJMc2027508
N Engl J Med 2020; 383:1893-1894
